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Abstract
As high-throughput sequencing technologies are becoming more widely adopted for analysing
pathogens in disease outbreaks there needs to be assurance that the different sequencing tech-
nologies and approaches to data analysis will yield reliable and comparable results. Conversely,
understanding where agreement cannot be achieved provides insight into the limitations of
these approaches and also allows efforts to be focused on areas of the process that need
improvement. This manuscript describes the next-generation sequencing of three closely
related viruses, each analysed using different sequencing strategies, sequencing instruments
and data processing pipelines. In order to determine the comparability of consensus sequences
and minority (sub-consensus) single nucleotide variant (mSNV) identification, the biological
samples, the sequence data from 3 sequencing platforms and the *.bam quality-trimmed align-
ment files of raw data of 3 influenza A/H5N8 viruses were shared. This analysis demonstrated
that variation in the final result could be attributed to all stages in the process, but the most critical
were the well-known homopolymer errors introduced by 454 sequencing, and the alignment pro-
cesses in the different data processing pipelines which affected the consistency of mSNV detec-
tion. However, homopolymer errors aside, there was generally a good agreement between
consensus sequences that were obtained for all combinations of sequencing platforms and data
processing pipelines. Nevertheless, minority variant analysis will need a different level of careful
standardization and awareness about the possible limitations, as shown in this study.
Introduction
Over the past decade, high-throughput sequencing technologies have evolved, providing faster,
cheaper, and less laborious alternatives to obtain (whole genome) DNA and RNA sequences
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compared to traditional Sanger sequencing [1, 2]. The use of next-generation sequencing
(NGS) technologies is continuously expanding and has revolutionized the field of genomics
and molecular biology.
In many fields of infectious disease research, nucleotide changes in DNA or RNA sequences
are used to monitor genetic adaptions indicative of evolution, the emergence of drug resis-
tance, immune evasion or as a tool in epidemiological tracing [3]. In clinical settings, sequenc-
ing information is used to improve diagnostics and prognosis. NGS technologies play an
increasingly important role in these processes as clinically or epidemiologically important
nucleotide changes can be present in the minority of DNA or RNA sequences only, which
might be missed with more traditional (consensus) sequencing methods which determine the
most abundant sequence variants in a population. Nucleotide variants that are present in only
a minority of the sequenced virus population are referred to as minority Single Nucleotide
Variants (mSNVs). These variants, initially occurring due to replication errors, can become
fixed in the population when they have some sort of evolutionary advantage, for instance,
mutations related to drug resistance. Furthermore, mSNVs can be also used for high-resoltion
molecular epidemiology, which becomes more and more important for outbreak assessment
[4, 5]. Traditional Sanger sequencing for instance has been described to detect minority vari-
ants provided they are present in at least 10% of the analysed DNA or RNA strands within a
sample [6, 7]. Hence, the use of traditional sequencing methods is usually restricted to obtain-
ing consensus sequences or to determine heterozygosity in diploid organisms. In contrast,
NGS technologies are able to detect low frequency mSNVs in sequence fragments or even
whole genomes. Typically, NGS sensitivity for minority sequence variant identification is
restricted to a level of variation of 0.1–1%, mainly due to sequencing related background errors
[8–10], but sensitivity can be increased using sophisticated approaches like circle sequencing
[11] or improved bioinformatic analysis workflows [10]. The reliability of mSNV analysis
using NGS methods is influenced by many factors, like the quantity and quality of the input
sample, the laboratory procedures, the type of sequencing platform and the software and
settings used to analyse the raw sequence data.
Due to the technical improvements, NGS technologies have become more important as
diagnostic tools to characterize pathogens in outbreak situations. However, the increasing use
of these technologies to address new and important (outbreak related) research and surveil-
lance questions emphasizes the need to determine the reproducibility of, and the important
technical considerations affecting, outcomes obtained by different laboratories following dif-
ferent protocols. Given this, comparative studies focusing on different platforms and data
analysis methods are essential to cross-validate different methodologies and determine the
reliability of newly obtained data. In addition, there is a growing need (as exemplified by the
recent Ebola and Zika virus outbreaks) to share also comprehensive sequencing data as quickly
as possible to help with source attribution and developing control strategies. However, the
underlying technologies and methods used for NGS are still diverse and there is a strong
demand for harmonization of laboratory procedures and approaches for a reliable and opti-
mized analysis of the data.
This study is part of the European Union’s HORIZON 2020 project “COMPARE” (http://
www.compare-europe.eu/), aiming to improve the analytical tools for emerging zoonotic
pathogens and its underpinning research. Here, the comparability of NGS output data
obtained from different sequence approaches were evaluated and demonstrated suitable shar-
ing strategies for comprehensive NGS data sets. In November 2014, a newly emerging strain
of highly pathogenic avian influenza (HPAI) virus was detected in several European countries
[12, 13]. In the United Kingdom [14], Germany [15], and The Netherlands [16–18] this sub-
type was detected in commercial poultry farms within a few days of one another. In each of
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those countries, NGS was used to generate whole-genome sequences rapidly after detection,
but as the laboratories in each country were working independently, different approaches were
used for both sequencing and data analysis, and the data were shared as part of a wider study
to determine the likely source of the outbreak [19]. It is important to determine whether the
different analytical approaches have any impact on the outcome. Therefore, the aim of this
study was to determine how comparable consensus and minority variant results were between
laboratories performing their standard analyses, and whether discrepancies could be attributed
to the sequence platform (SP), the data processing platform (DPP) or a combination of both.
With the lack of a ground truth/gold standard, all datasets obtained were compared amongst
each other. The hypothesis we test in this study is that outputs from NGS analysis of viruses
will be comparable irrespective of laboratory, sequencing platform and data analysis platform.
Therefore, virus isolates obtained in each of the three countries (United Kingdom, Germany
and the Netherlands) were shared between these three partners and subsequently sequenced
and analysed in each of the three laboratories according to local procedures. In addition, the
use of a specially designed data sharing platform, a COMPARE “Data Hub” at EMBL-EBI,
Hinxton UK, was evaluated. This study presents genome coverage data, consensus sequences,
the analysis of the comparability of mSNV identifications of the different SPs, and DPPs.
Our hypothesis was confirmed at the consensus sequence level, since consensus sequences
could be reproduced independent of the combination of SP and DPP used. However, the iden-
tification of minority variants appeared to be poorly reproducible, primarily due to the well-
known errors in 454 sequencing, and due to differences induced by the alignment processes in
the different DPPs. The interpretation of minority variant analysis thus needs a different level
of careful standardization and awareness about the possible limitations as shown in this study.
Materials and methods
Experimental design
Three avian influenza A virus isolates that were obtained from three different avian species
during the 2014/15 outbreak of HPAI H5N8 virus in Europe were shared among three institu-
tions in the United Kingdom (Animal Plant and Health Agency [APHA]), Germany (Fried-
rich-Loeffler-Institut [FLI]) and the Netherlands (Erasmus Medical Center [EMC]), later
referred to as anonymized institutions I, II and III (Fig 1). All three institutions sequenced all
three virus isolates according to their own standard procedures. Adaptors used in the sequenc-
ing processes were trimmed off before the raw sequence data files were shared. The sequence
data files (�.fastq files), alignment files (�.bam files), sample metadata and experimental meta-
data were shared between the three laboratories and analysed in their own DPPs yielding
sequence datasets for each virus (Table 1). This approach enabled to separate the biological
features of the viruses from variation introduced by technical methodology. Data sharing was
facilitated via a “Data Hub” provided by the EMBL-EBI’s European Nucleotide Archive (ENA)
in the framework of the COMPARE collaborative project; all data were stored and subse-
quently published in ENA [20] (https://www.ebi.ac.uk/ena, for the accession numbers, see
Table 1). ENA is an open repository for sequence and related data and a member of the Inter-
national Nucleotide Sequence Database Collaboration (INSDC; http://www.insdc.org/) [21]. A
full description of the COMPARE Data Hub system is provided in a preprint version of Amid
et al. [22]. First, consensus sequences derived from a preliminary analysis were compared and
one overarching consensus sequence was determined for each gene segment for each virus.
This custom-made consensus was used by all three institutions as the reference genome for
undertaking mSNV analysis. The resulting nine mSNV reports (originating from three whole-
genome raw data sequences times three DPPs) were combined for all three viruses in one
Comparison of sequencing methods and data processing pipelines
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spreadsheet file per virus to check the reproducibility of mSNV identification when using dif-
ferent combinations of SP and DPP. The experimental design is summarized in Fig 1.
Samples
All samples were obtained from outbreaks in commercial poultry holdings. Isolate A/duck/
England/36254/2014 was obtained from pooled intestinal material from index case ducks
(Anas platyrhynchos domesticus). Tissue homogenate material was inoculated into embryo-
nated chicken eggs and allantoic fluid was harvested at 1 day post-inoculation [14]. The Dutch
isolate (A/chicken/Netherlands/EMC-3/2014) was obtained by passaging lung material of a
dead commercial layer hen (Gallus gallus domesticus) in MDCK cells twice and harvesting the
supernatant after approximately 40 hours post-inoculation [23]. The German isolate (A/tur-
key/Germany/AR2485/2014) originated from lung tissue of a commercially kept turkey
(Meleagris gallopavo) and was passaged in embryonated chicken eggs [15]. (Table 1).
Sequencing
Institution I: SP1. RNA was extracted using a Qiagen QIAamp viral RNA mini kit (Qia-
gen, Germany) according to the manufacturers’ instructions except that carrier RNA was
omitted from the AVL lysis buffer and the sample was eluted in 50μl RNAse-free water. RNA
was then processed to double-stranded cDNA (cDNA Synthesis System, Roche) using random
hexamers and purified using magnetic beads (AmpureXP, Beckman Coulter, USA). The dou-
ble-stranded cDNA was diluted to 0.2 ng/μl and used to produce a sequencing library using
the NexteraXT kit (Illumina, USA). Libraries were then sequenced in paired-end mode on an
Illumina MiSeq (Illumina, USA), with run lengths varying from 2 x 75 bases (UKDD virus) to
2 x 150 bases (NLCH and DETU viruses) depending on whether time-constraints were imple-
mented to provide a rapid response to an outbreak. Demultiplexing and removal of sequencing
adapters was done by the MiSeq RTA software to generate raw fastq files. SP1 process included
a limited 12-cycle PCR enrichment of the library. Post-hoc analysis showed that duplication
Fig 1. Flowchart of the experimental design. SP: sequence platform; DPP: data processing pipeline.
https://doi.org/10.1371/journal.pone.0229326.g001
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levels were less than 0.02% of the total reads which were considered to have negligible impact
on the results.
Institution II: SP2. RNA was extracted using a combined approach with TRIzol (Thermo
Fisher Scientific, USA) and an RNeasy Kit (Qiagen, Germany). Further concentration and
cleaning was done with Agencourt RNAClean XP magnetic beads (Beckman Coulter, USA).
RNA was quantified using a Nanodrop UV spectrometer ND-1000 (Peqlab, Germany) and
used as template for cDNA synthesis with a cDNA Synthesis System (Roche, Germany) with
random hexamers. Fragmentation of the cDNA applying a target size of 300 bp was done with
a Covaris M220 ultrasonicator. The sonicated cDNA was used for library preparation using
Illumina indices (Illumina, USA) on a SPRI-TE library system (Beckman Coulter, USA) using
a SPRIworks Fragment Library Cartridge II (for Roche FLX DNA sequencer; Beckman Coul-
ter, USA) without automatic size selection. Subsequently, upper and lower size exclusion of
the library was done with Ampure XP magnetic beads (Beckman Coulter, USA). The libraries
were quality checked using High Sensitivity DNA Chips and reagents on a Bioanalyzer 2100
(Agilent Technologies, Germany) and quantified via qPCR with a Kapa Library Quantification
Kit (Kapa Biosystems, USA) on a Bio-Rad CFX96 Real-Time System (Bio-Rad Laboratories,
USA). SP2 did not amplify sample nor library. Sequencing was done on an Illumina MiSeq
using MiSeq reagent kit v3 (Illumina, USA) resulting in paired end sequences with a read
length of 300. Demultiplexed and adapter-trimmed reads were used to generate raw fastq files.
Institution III: SP3. RNA was extracted using the High Pure RNA isolation kit (Roche
Diagnostics, Germany) according to manufacturer’s instructions. RNA was converted to cDNA
using the SuperScript III Reverse Transcriptase kit (Invitrogen, Thermo Fisher, USA) as
described previously [24], and amplified by PCR using primers covering the full viral genome
(S1 Table). All 32 PCR fragments from approximately 400–600 nucleotides in length, were
sequenced using the 454/Roche GS-FLX sequencing platform. The PCR fragments were pooled
in equimolar ratio and purified using the MinElute PCR Purification kit (Qiagen, Germany)
according to the manufacturer’s instructions. Rapid Library preparation, Emulsion PCR and
Next Generation 454-sequencing were performed according to instructions of the manufacturer
(Roche Diagnostics, Germany). Protocols are described in the following manuals: Rapid Library
Preparation Method Manual (Roche; May 2010), emPCR Amplification Method Manual–Lib-L
(Roche; May 2010) and Sequencing Method Manual (Roche; May 2010). All three samples were
sequenced in one run. Samples were pooled using MID adaptors to determine which sequences
came from which sample, each sample was assigned two different MID’s. Demultiplexing and
basic trimming was done by CLC-bio software to generate raw fastq files (S1 File).
Data processing
Institution I: DPP1. In the FluSeqID script (https://github.com/ellisrichardj/FluSeqID)
the following steps are run automatically: the mapping of raw sequence data to the host
genome (BWA v0.7.12-r1039 [25]), extracting reads that do not map to the host (Samtools
v1.2 [26]), assembling non-host reads (Velvet v1.2.10 [27]), identification of the closest match
for each genome segment (BLAST v2.2.28 [28] using the custom databases generated from the
Influenza Research Database as indicated in the GitHub repository), mapping original data to
the top reference segments (BWA), calling new consensus sequences (vcf2consensus.pl), per-
forming further iterations of the last two steps to improve new consensus (IterMap), and
finally outputting the genome consensus sequence. The data processing pipeline has in-build
defaults for k-mer and coverage cut-off for de novo assembly, and the e-value cut-off for
BLAST, which can be changed via command line options (see https://github.com/ellisrichardj/
FluSeqID). Since the aligner (BWA-MEM) used performs soft-clipping and ignores low
Comparison of sequencing methods and data processing pipelines
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quality data, quality trimming is unnecessary. For mSNV analysis, the reads were mapped to
the unified consensus using BWA. Samtools was used to generate a pileup file which was then
analysed using custom python and R scripts to determine the depth of coverage and basecalls
at each position (available at https://github.com/ellisrichardj/MinorVar). The combination of
BWA-MEM and samtools was shown to be accurate for SNV identification [29]. In order to be
included in the final output the minimum basecall quality was 20 and the minimum mapping
quality was 50.
Institution II: DPP2. Raw sequence data were analysed and mapped using the Genome
Sequencer software suite (v. 3.0; Roche, Mannheim, Germany) and the Geneious software
suite (v. 9.0.5; Biomatters, Auckland, New Zealand). Raw reads were trimmed and subsets of
each trimmed dataset were assembled de novo to generate reference sequences for each data
set (Newbler Assembler of Genome Sequencer software suite v. 3.0; Roche, Mannheim, Ger-
many). The trimmed raw influenza virus reads were mapped to the reference sequences (New-
bler Mapper of Genome Sequencer software suite v. 3.0; Roche, Mannheim, Germany). The
output assemblies were imported into the Geneious software suite (v. 9.0.5; Biomatters, Auck-
land, New Zealand) for further analysis and processing. Regions of low and high coverage
(threshold was 2 x standard deviations from the mean for low and high coverage) and regions
of low quality (minimum quality/phred score 20) were evaluated and if necessary, excluded
from further analyses. Consensus sequences were generated and annotated using annotated
reference sequences. Sequences were compared, and annotations that matched with a similar-
ity (> 90%) were copied. This was done on nucleotide sequences and also for translation in all
six reading frames. Annotations were manually inspected and curated. Trimmed raw reads of
the datasets or subsets thereof were mapped to the consensus, mapping was fine-tuned and
mSNVs were determined using generic SNP finder of the Geneious software suite, applying
parameters of maximum p-value of 10−5 and filter for strand bias. The threshold for SNP iden-
tification was set at 1%, and variants were checked manually for accuracy.
Institution III: DPP3. Raw sequence data were analysed and mapped using the CLC
Genomics software package, workbench 8 (CLC Bio). Reads obtained by 454 sequencing were
sorted by MID adaptor, quality-trimmed, and analysed using the parameters as shown in S1
File. In short, after sorting by MID, the sequence reads were trimmed at 30 nucleotides from
the 30 and 50 ends to remove all primer sequences. Data from the shared Illumina sequence
files had already been trimmed and were imported in CLC Bio without additional processing
steps (S1 File). Reads were initially aligned to their own reference sequences that were
uploaded during the H5N8 outbreak (Gisaid accession numbers EPI-ISL-169282 (NLCH),
EPI-ISL-167904 (UKDD) and EPI-ISL-169273 (DETU)). Consensus sequences were automati-
cally generated by CLC after alignment to the reference, for detailed settings see S1 File. For
the mSNV analysis the raw data were mapped to the new custom-made consensus sequences
per gene segment per sample. Fastq files of these alignments were shared with the other institu-
tions. The threshold for mSNV identification was set at 1%, and registered minority variants
were checked manually for accuracy (minimal quality/phred score 20).
Determining the influence of the DPP alignment steps versus DPPs mSNV identifica-
tion methods. Data processing pipelines process raw data in several steps, roughly divided
into trimming, aligning data to a reference sequence, and variant calling (the mSNV identifica-
tion procedure). In order to determine to what extent the trimming and subsequent alignment
processes contributed to the observed differences the nucleotide coverage results obtained by
the three DPPs when aligning the same SP raw datasets were compared. To study the influence
of the mSNV identification process, quality-trimmed alignment files that had been generated
by each DPP and shared as �.bam files were subjected to the mSNV identification process used
in DPP3 to determine the differences in mSNV detection output when only the alignment
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processes differed. DPP3 was randomly picked for this analyses, mSNV detection parameters
were set to the institutions default settings for mSNV identification using CLC-bio software
and can be seen in the S1 File.
Data sharing
To test the applicability of real-time sequence data sharing within the COMPARE network,
all raw sequence data used in this study were uploaded to and shared via a “Data Hub” in the
environment of the European Nucleotide Archive (ENA). Each institution received its own
study accession in which all raw sequence data files and metadata files were assigned with
individual experimental accession numbers (Table 1). In addition to the sequence data, all
trimmed alignment files (�.bam) have been uploaded to the ENA. Using these hubs, sharing
between institutions was facilitated and immediate access to the data prior to the public release
was possible to enable joint evaluation and comparison. All data files have been made publicly
available via the ENA (https://www.ebi.ac.uk/ena).
Designing the custom-made consensus sequences
Each institution produced a consensus sequence for the 8 influenza gene segments (PB2, PB1,
PA, HA, NP, NA, MP, NS) for each of the three viruses. The obtained consensus sequences
were aligned using the BioEdit sequence alignment editor (version 7.2.0) [30]. Raw sequence
data from each SP were initially aligned to their own reference sequences that were uploaded
during the H5N8 outbreak (Gisaid accession numbers EPI-ISL-169282 (NLCH), EPI-ISL-
167904 (UKDD) and xxx (DETU)).
mSNV analysis comparison
For the mSNV analyses the custom-made consensus for each virus isolate was used as a refer-
ence for mapping, thereby standardizing positions within the genome to make comparison
between institutions easier. To avoid unnecessary increases in analytical time and memory,
datasets were down-sampled to 100.000 reads per sample when needed. Each DPP produced
a report on the identified mSNVs in a tabulated format. The analysis output files were filtered
for mSNVs only, thereby ignoring detected nucleotide insertions and deletions (InDels).
There is a current lack of data or evidence-based approaches on how to calculate the required
sequence depth (i.e. coverage) for mSNV analyses an evidence-based. In this study, a mini-
mum coverage threshold for the identification of mSNVs was applied. This minimum nucleo-
tide coverage (i.e. number of reads per nucleotide after trimming) was determined using a
basic sample size calculation method, n = log β / log p’ [31]. Here β represents the required
power (e.g. for 95% chance of detecting something β = 0.05), and p’ is 1—the proportion of
events that you want to detect. For a 95% certainty of detecting a variant at 1%, a minimum
coverage of 298 reads per position is needed. For variants that occur in�5% of reads, the
number of reads required is>58, and for variants that occur in�10% of the reads the mini-
mum coverage is >28. For the mSNV identification literature commonly uses the mSNV cut-
off frequencies of�10%,�5% and�1%. However, it needs to be noted that these cut-off
values are arbitrary. Therefore, where depth of coverage was sufficient, this study will report
mSNV detected with a frequency of�1%, but initial comparisons started with positions show-
ing mSNVs with frequencies of�10% in at least one of the SP/DPP combinations, followed by
those with mSNV of�5% -<10%, and lastly those�1%-<5%. For all those positions identi-
fied, the number of reads and number of variant nucleotides in all other SP/DPP combinations
for that position will be noted regardless of frequencies.
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Results
In order to determine the comparability of consensus sequences and mSNV identification the
biological samples, the sequence data from 3 SPs and the �.bam quality-trimmed alignment
files of raw data of 3 influenza A/H5N8 viruses were shared. All data sets were subsequently
analysed in 3 different DPPs. The resulting 9 mSNV reports per virus (3 SP data sets each ana-
lysed in 3 DPPs) were evaluated for comparability of mSNV identification using different com-
binations of SP and DPP.
Data sharing
Data sharing using the COMPARE “Data Hub” provided by ENA proved to be easy, quick and
successful. The “Data Hub” enables the File Transport Protocol (FTP) protected upload and
download of large data files and facilitates sharing between collaborators with the possibility to
evaluate and compare all data prior to their public release by generating and specifically shar-
ing accession numbers using standard ENA procedures. The Data Hub used an influenza virus
sample checklist. In addition, data sets are ultimately made publicly and through the INSDC
network globally available and accessible in real-time as required without further upload to a
different repository. Full details of the COMPARE Data Hub system are available in a submit-
ted manuscript [22]. In summary, this process was suitable for quick data sharing in an out-
break scenario.
Designing the custom-made consensus sequences
For each of the 8 gene segments of the 3 viruses separately, 9 initial consensus sequences (3 SPs
x 3 DPPs) were generated, resulting in 72 consensus sequences per virus. The custom-made
consensus sequence per virus and per gene segment was 1) trimmed to a length represented by
all 9 initial consensus sequences and 2) nucleotides had to be identical to at least 6/9 consensus
sequences to be included. Although some sequences contained insertions or deletions, those
could always be corrected for using the other SP sequences following the criteria mentioned
previously. This resulted in a unique custom-made consensus for each gene segment for all
three viruses.
Consensus sequences
When ignoring insertions and deletions in the homopolymer regions of the 454 data for most
gene segments the identified consensus sequences were identical regardless of the SP and DPP
combinations used with the exemption of the differences mentioned in Table 2. However, the
number of insertions and deletions in homopolymer regions of the SP3 sequences were con-
siderable in all 3 viruses. There was no clear difference in the number of insertions and dele-
tions related to homopolymer regions between the different DPPs (20, 17 and 18 for DPP 1, 2
and 3 respectively). Nucleotide differences that were not related to homopolymer regions were
only observed for sequences obtained in SP3 and SP2 data when processed in DPP1.
In summary, the homopolymer errors inherent in the 454 dataset caused problems for all
DPPs, as expected. Consensus sequences generated by DPP1 from SP3 (454) data showed
some unexpected differences, but it performed well with the SP1 data formats it was designed
for and reasonably well with SP2 data. Overall, the consensus sequences can be reproduced
by all DPPs using Illumina data but that the analysis of the 454 data from SP3 was more prob-
lematic, as it would require editing of the sequences at homopolymer regions. Consensus
sequences from this study can be found in the S2 Table.
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Table 2. The differences in consensus sequences obtained from each SP/DPP combination, sorted per virus and
per gene segment.
Virus Segment Start� End Number of InDels at homoplymer regions�� Other nucleotide differences���
NLCH PB2 1 2280 2 (DPP1) C506A (SP3)
2 (DPP3) G2101R (SP3)
PB1 1 2277 1 (DPP1/DPP2/DPP3)
1 (DPP1/DPP2) A949W (SP3)
1 (DPP2/DPP3) 2272 ins AAG (SP2)
1 (DPP3)
PA -6# 2190 1 (DPP1/DPP2) ND
2 (DPP1)
HA 7 1704 1 (DPP2/DPP3) A427W (SP2)
NP 1 1497 1 (DPP1) C420Y (SP3)
NA 4 1419 ND ND
MP -5# 982 ND ND
NS 1 838 ND ND
DETU PB2 1 2287 1 (DPP1/DPP2/DPP3) 2272 Del A (SP3)
3 (DPP1)
PB1 1 2277 1 (DPP1/DPP2/DPP3) T956C (SP3)
1 (DPP1)
1 (DPP2)
1 (DPP3)
PA 7 2189 1 (DPP1/DPP2) ND
HA 1 1728 1 (DPP2/DPP3) ND
NP 1 1497 2 (DPP3) ND
NA 1 1413 1 (DPP1) 778 ins CCA (SP3)
MP -1# 982 1 (DPP2) ND
NS 2 838 ND ND
UKDD PB2 1 2298 1 (DPP1/DPP2/DPP3) C504T (SP3)
1 (DPP3) C506M (SP3)
PB1 1 2277 1 (DPP1/DPP2/DPP3) T951W (SP3)
1 (DPP2/DPP3)
PA 1 2151 2 (DPP1) ND
1 (DPP2)
HA 1 1704 1 (DPP2/DPP3) ND
NP 1 1497 1 (DPP3) T1003Y (SP2)
NA 4 1420 ND 782 del TA (SP3)
MP -5# 982 1 (DPP2) ND
NS -5# 849 ND ND
The letter in brackets represents the DPP (column 5) or the SP (column 6) where the insertions/deletions or
mutations were detected. InDel: insertions or deletion; SP: Sequence platform; DPP: Data processing pipeline; ND:
not detected.
� Start is counted from the ATG start codon;
�� Exclusively identified in SP3 sequence data, InDels related to homopolymer regions;
��� Exclusively identified in DPP1;
# ’-’ indicates the number of nucleotides before the ATG start codon included in the consensus
https://doi.org/10.1371/journal.pone.0229326.t002
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The mSNV analysis comparison
Nucleotide coverage and the influence of DPP-dependent alignment. The observed
number of reads per nucleotide (referred to as nucleotide coverage) differed depending on the
SP/DPP combination. All DPPs handled both 454 and Illumina data formats, although some
modifications (settings for the bwa mapper to handle single end 454 data) were required for
DPP1, which was specifically designed for Illumina paired-end reads. The observed nucleotide
coverages showed near to identical profiles for all three viruses. The coverage results obtained
from the three different SPs and DPPs for the NLCH virus (Fig 2) and for the other two viruses
(S1 Fig) were plotted. In general, lower nucleotide coverage was observed at the termini of
each gene segment. The SP3 data showed more variation in nucleotide coverage within gene
segments compared to SP1 and SP2 data, due to the sequencing of 32 PCR amplicons. The
non-normalised number of raw sequence reads and influenza virus reads per virus per SP can
be found in the S3 Table.
The differences in nucleotide coverage were visualized for the three different SP raw datasets
analysed with the same DPP (Fig 2A). Overall, SP3 data (green lines) showed a lower coverage
compared to SP1 (purple) and SP2 data (yellow). The overall coverage for SP1 and SP2 data
was similar with small variations for different viruses and DPPs. The shorter read lengths in
SP1 virus data did not appear to have influenced the overall nucleotide coverage substantially.
The differences in nucleotide coverage introduced by different alignment procedures were
also assessed, by comparing the coverage results for each SP raw dataset analysed with the
three different DPPs (Fig 2B). DPP2 (orange lines) generally retained the highest nucleotide
coverage for data from the different SPs. However, DPP3 (grey lines) generally also retained
high coverage for SP3 data, for which it was optimized. The nucleotide coverage of SP3 data
showed larger variation between the three different DPPs, leading to differences in nucleotide
coverage up to 50% depending on the DPP, because DPP1 and DPP2 were not optimized for
this SP. Data from SP2 were handled very similar by all three DPPs.
In conclusion, both the SP and the DPP influenced the number of reads per nucleotide
position. SP3 showed the lowest output in number of reads compared to SP1 and SP2 Illumina
data. The influence of the DPP depended highly on the data input, with best DPP performance
for the SP dataset for which it was optimized.
The mSNV identification. The mSNV identification thresholds were set to�1% in all
DPPs. Because of the high number of mSNVs identified, the comparison of these mSNVs
started with a manually set arbitrary threshold of�10% that was subsequently decreased to
�5%, and�1%. A mSNV position was identified when at least 1 of the SP/DPP combinations
showed a variant that exceeded the frequency threshold, and when the coverage at that posi-
tion exceeded the minimum number of reads needed to detect that variant with a 95% proba-
bility, as described previously. The presence of mSNV and coverage for all SP/DPP
combinations were compared for each of the positions in which a mSNV had been detected in
at least one of the combinations. The coverages indicated for those positions where no mSNVs
were detected were derived from the alignment files and were not subjected to possible addi-
tional read filtering parameters in the mSNV identification process. The average quality (Q-
score/phred score) was set to or exceeding 20.
Ten positions across the three virus genomes were identified with mSNVs occurring in�10%
of reads. Three of the mSNVs (NLCH:PB2 G1879A, NLCH:PB2 G2101A and DETU:HA T963C)
were detected in all SP/DPP combinations but with slightly different relative abundance. The other
mSNVs were identified in only one (n = 6) or two (n = 1) of the SP/DPP combinations (Table 3).
Thirty-seven positions were identified with mSNVs occurring in�5% of reads. Of those,
the same mSNV was identified in all SP/DPP combinations for 9 positions (24,3%), in seven or
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Fig 2. Nucleotide coverage. The non-normalised nucleotide coverage displayed as number of nucleotides per position
for full genome sequences of the NLCH virus reads mapped to the NLCH reference sequences. Panel A shows the
coverage results for the same SP dataset in the three different DPPs (DPP1: purple; DPP2: orange; DPP3 grey) for each
of the SP datasets. Panel B shows the coverage when the same DPP is used to analyse data from the three different SPs
(SP1: lilac; SP2: yellow; SP3: green) for each of the DPPs. The X-axis represents the position in the genome, the Y-axis
represents the number of sequence reads per position.
https://doi.org/10.1371/journal.pone.0229326.g002
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Table 3. The minority variants occurring in at least one of the sequence platform—Data processing pipelines as a�5% variant.
Virus Position Sequence platform Data processing pipeline
1 2 3
Minor variants Percentage Minor variants Percentage Minor variants Percentage
NLCH PB2.1879 G!A 1 81/1301 6,2% 246/2716 9,1% 112/1203 9,3%
2 47/956 4,9% 117/1137 10,3% 114/1064 10,7%
3 49/530 9,2% 131/1341 9,8% 129/1338 9,6%
PB2.2101 G!A 1 53/1118 4,7% 261/2704 9,7% 110/897 12,3%
2 21/1578 1,3% 125/1875 6,7% 121/1463 8,3%
3 13/542 2,4% 199/1433 13,9% 199/1435 13,9%
PB2.2277 T!G 1 ND/479 <1% 86/1008 8,5% 33/190 17,4%
2 ND/557 <1% ND/623 <1% ND/534 <1%
3 ND/680 <1% ND/1117 <1% ND/1024 <1%
PB1.87 A!G 1 ND/818 <1% ND/1754 <1% ND/1114 <1%
2 25/230 10,9% ND/376 <1% ND/328 <1%
3 ND/275 <1% ND/537 <1% ND/537 <1%
PB1.2240 G!C 1 ND/664 <1% 54/1341 4,0% 38/418 9,1%
2 ND/1231 <1% ND/1271 <1% ND/1233 <1%
3 ND/161 <1% ND/277 <1% ND/276 <1%
PB1.2268 A!G 1 ND/336 <1% 29/641 4,5% 11/176 6,3%
2 ND/993 <1% ND/1026 <1% ND/1002 <1%
3 ND/53 <1% ND/159 <1% ND/148 <1%
HA.104 A!G 1 ND/733 <1% ND/1761 <1% ND/1151 <1%
2 ND/437 <1% ND/1370 <1% ND/1156 <1%
3 ND/1 <1% ND/105 <1% 12/105 11,4%
HA.1689 T!C 1 ND/390 <1% ND/694 <1% 11/217 5,1%
2 ND/2018 <1% ND/4083 <1% ND/3979 <1%
3 ND/937 <1% ND/1669 <1% ND/1680 <1%
NP.105 A!G 1 ND/182 <1% ND/449 <1% ND/343 <1%
2 83/1507 5,5% ND/1890 <1% ND/1804 <1%
3 ND/89 <1% ND/704 <1% ND/702 <1%
NP.1239 A!T 1 32/2428 1,3% 279/5410 5,2% ND/3092 <1%
2 ND/2345 <1% ND/2643 <1% ND/2453 <1%
3 ND/1711 <1% ND/2111 <1% ND/2117 <1%
NP.1489 G!A 1 ND/182 <1% 26/336 7,7% ND/172 <1%
2 ND/436 <1% ND/452 <1% ND/444 <1%
3 ND/1320 <1% ND/1799 <1% ND/1799 <1%
NS.833 A!T 1 ND/187 <1% ND/287 <1% 5/88 5,7%
2 ND/1224 <1% ND/1327 <1% ND/1284 <1%
3 ND/1367 <1% ND/2430 <1% ND/2333 <1%
DETU PB2.1054 T!C 1 69/1369 5,0% 168/2637 6,4% 97/1304 7,4%
2 60/1477 4,1% 115/1836 6,3% 99/1605 6,2%
3 6/392 1,5% 94/2038 4,6% 48/1054 4,6%
PB2.2257 A!C 1 ND/867 <1% ND/1563 <1% 24/463 5,2%
2 ND/531 <1% ND/581 <1% ND/378 <1%
3 ND/893 <1% ND/2286 <1% ND/1346 <1%
PB2.2277 T!G 1 ND/644 <1% 52/1150 4,5% 27/307 8,8%
2 ND/418 <1% ND/472 <1% ND/284 <1%
3 ND/1208 <1% ND/1948 <1% ND/1209 <1%
(Continued)
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Table 3. (Continued)
Virus Position Sequence platform Data processing pipeline
1 2 3
Minor variants Percentage Minor variants Percentage Minor variants Percentage
PB1.14 C!T 1 ND/144 <1% 48/433 11,1% ND/239 <1%
2 ND/90 <1% ND/355 <1% ND/304 <1%
3 ND/562 <1% ND/792 <1% ND/496 <1%
PB1.23 T!G 1 ND/207 <1% 30/535 5,6% ND/315 <1%
2 ND/103 <1% ND/365 <1% ND/319 <1%
3 ND/699 <1% ND/950 <1% ND/609 <1%
PB1.87 A!G 1 ND/744 <1% ND/1644 <1% ND/1076 <1%
2 49/365 13,4% ND/677 <1% ND/576 <1%
3 ND/721 <1% ND/1156 <1% ND/793 <1%
PB1.2240 G!C 1 ND/757 <1% 23/1517 1,5% 26/515 5,0%
2 ND/944 <1% ND/985 <1% ND/806 <1%
3 ND/274 <1% ND/439 <1% ND/253 <1%
PB1.2268 A!G 1 5/470 1,1% 33/928 3,6% 22/278 7,9%
2 ND/798 <1% ND/829 <1% ND/671 <1%
3 ND/109 <1% ND/259 <1% ND/123 <1%
PB1.2271 A!G 1 12/446 2,7% 59/901 6,5% 16/263 6,1%
2 ND/729 <1% 47/810 5,8% 40/649 6,2%
3 1/32 3,1% ND/123 <1% 2/83 2,4%
HA.867 C!T 1 59/1533 3,8% 206/3183 6,5% 104/1537 6,8%
2 59/2031 2,9% 150/2525 5,9% 127/2253 5,6%
3 11/180 6,1% 48/647 7,4% 28/385 7,3%
HA.963 T!C 1 122/1401 8,7% 446/3071 14,5% 189/1419 13,3%
2 90/1517 5,9% 318/2189 14,5% 247/1828 13,5%
3 5/69 7,2% 107/606 17,7% 47/293 16,0%
NP.1491 C!A 1 ND/278 <1% 71/583 12,2% ND/206 <1%
2 ND/723 <1% ND/769 <1% ND/692 <1%
3 ND/799 <1% ND/2031 <1% ND/1206 <1%
NA.65 T!C 1 19/503 3,8% 52/1229 4,2% 16/467 3,4%
2 20/662 3,0% 50/1104 4,5% 45/992 4,5%
3 24/557 4,3% 53/1099 4,8% 37/727 5,1%
NA.78 T!C 1 23/599 3,8% 57/1403 4,1% 20/557 3,6%
2 21/692 3,0% 55/1147 4,8% 50/1033 4,8%
3 23/580 4,0% 51/1124 4,5% 37/735 5,0%
NA.89 T!C 1 23/713 3,2% 55/1670 3,3% 22/651 3,4%
2 23/798 2,9% 56/1261 4,4% 50/1134 4,4%
3 24/580 4,1% 55/1196 4,6% 40/775 5,2%
NA.117 T!C 1 37/908 4,1% 87/2140 4,1% 36/818 4,4%
2 28/1102 2,5% 67/1631 4,1% ND/1459 <1%
3 22/531 4,1% 57/1276 4,5% 42/812 5,2%
NA.126 T!C 1 37/983 3,8% 83/2294 3,6% 36/876 4,1%
2 31/1126 2,8% 72/1676 4,3% 65/1502 4,3%
3 26/519 5,0% 62/1395 4,4% 43/812 5,3%
(Continued)
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eight of the SP/DPP combinations for 2 positions (5,4%) and in at least two SP/DPP combina-
tions for 19 positions (51.4%), although not always in a frequency of�5%. However, for 18
positions (48.6%) the mSNV was not reproduced at a�1% frequency in any of the other SP/
DPP combinations (Table 3). Focussing on the separate SP data analysed in the 3 DPPs, most
of the identified positions with�5% mSNVs in at least 1 SP/DPP combination were identified
in SP1 data (47%) followed by SP2 (29%) and SP3 (24%) data.
Looking at the�5% mSNV reproducibility per SP dataset in all three DPPs within these
thirty-seven positions, forty-eight SP datasets showed a�5% mSNV in at least one of the DPP
outputs. Additionally, for eleven positions, all in the DETU virus, the variant was reproduced
by all DPPs, however at a<5% frequency (for instance SP3 data at PB2.1054, and SP1 and SP2
data at NA.65) In 53% (31/59) of cases the same mSNVs from 1 SP dataset was reproduced in
all three DPP’s in at least a�1% frequency, in 31% (18/59) of cases the variant was only
detected in 1 DPP even though coverage in the other DPPs was theoretically high enough to
detect variants at a 1% level.
Lowering the threshold value to a mSNV frequency of�1% resulted in a large increase in
the number of positions identified with mSNVs. To investigate the reproducibility of these
mSNVs, the data for all 3 viruses was combined per SP in the three DPPs (influence of DPP),
Table 3. (Continued)
Virus Position Sequence platform Data processing pipeline
1 2 3
Minor variants Percentage Minor variants Percentage Minor variants Percentage
UKDD PB2.2277 T!G 1 ND/415 <1% 28/507 5,5% ND/475 <1%
2 ND/589 <1% ND/620 <1% ND/601 <1%
3 ND/1140 <1% ND/1996 <1% ND/2065 <1%
PB1.87 A!G 1 ND/387 <1% ND/440 <1% ND/439 <1%
2 26/327 8,0% 32/395 8,1% ND/351 <1%
3 ND/617 <1% ND/1133 <1% ND/1136 <1%
PB1.728 C!A 1 ND/750 <1% ND/832 <1% ND/836 <1%
2 ND/776 <1% 52/928 5,6% ND/829 <1%
3 ND/2459 <1% ND/4290 <1% ND/4293 <1%
PB1.730 C!T 1 ND/742 <1% ND/824 <1% ND/826 <1%
2 ND/767 <1% 57/1008 5,7% ND/832 <1%
3 ND/2339 <1% ND//4286 <1% ND/4289 <1%
PB1.883 G!C 1 ND/942 <1% ND/997 <1% ND/997 <1%
2 ND/1689 <1% ND/1865 <1% ND/1760 <1%
3 ND/2479 <1% 47/690 6,8% ND/3681 <1%
PA.49 G!C 1 ND/103 <1% 6/117 5,1% ND/115 <1%
2 ND/337 <1% ND/435 <1% ND/392 <1%
3 ND/111 <1% ND/207 <1% ND/204 <1%
PA.82 C!T 1 ND/155 <1% ND/180 <1% ND/177 <1%
2 ND/695 <1% ND/809 <1% ND/745 <1%
3 ND/64 <1% ND/247 <1% 30/248 12,1%
NS.811 G!T 1 ND/221 <1% 17/270 6,3% ND/249 <1%
2 ND/2452 <1% ND/2725 <1% ND/2557 <1%
3 ND/3117 <1% ND/4125 <1% ND/4139 <1%
Colours display the variant frequency with�10% (green), 5–10% (purple) and <5% (pink). ND: not detected.
https://doi.org/10.1371/journal.pone.0229326.t003
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and per DPP analysing data from the three SPs (influence of SP). The genome positions with
�1% variants were listed per SP/DPP combination and entered in the program Venny 2.1 that
calculated the overlapping positions as a fraction of the total number of positions between the
SP/DPP combinations as compared to the total number of positions, resulting in Fig 3. It
needs to be noted that especially SP3 did not always reach the minimum coverage require-
ments and may therefore not be suitable to detect low-frequency variants with (see also
Table 4). Positions where the coverage in one or more of the nine SP/DPP combinations
didn’t meet the minimum required coverage of 298 were not included in the comparison in
Fig 3. The reproducibility of�1% variants using one SP dataset in all three DPPs was 10%,
9.4% and 31.1% for SP1, SP2 and SP3 sequences, respectively. The reproducibility of�1% vari-
ants using raw data of a virus sequenced in three different SPs was 20%, 7.4% and 22.6% for
DPP1, DPP2 and DPP3 respectively (Fig 3). Most�1% variants were not reproduced by any
of the other DPPs processing the same SP data (~75%) for SP1 and SP2 data. This was less for
Fig 3. The reproducibility of�1% variants with sufficient coverage (>298) for all sequence data combined. Each figure shows the number of�1%
variants detected per sequence platform (SP, top row) and data processing pipeline (DPP, bottom row) for SP1/DPP1 (left column), SP2/DPP2 (middle
column), and SP3/DPP3 (right column). The colours represent the different DPPs and SPs respectively, in which the>1% variants were detected: SP1/
DPP1 (purple), SP2/DPP2 (yellow) and SP3/DPP3 (green). Positions with�1% variants that were identified in more than one of the SPs or DPPs
respectively are displayed in the overlapping coloured areas, the centre part representing the number of�1% variants that were detected with all three
DPPs (top row) or SPs (bottom row). The total number of positions with�1% variants detected was 250in SP1, 213 in SP2, 45 in SP3, and 50 in DPP1,
353 in SP2, and 93 in SP3. This figure was produced using Venny 2.1.
https://doi.org/10.1371/journal.pone.0229326.g003
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Table 4. The minority variants occurring in at least one of the sequence platform—Data processing pipelines as a
�1% variant in the HA segment of the DETU sample with a minimum coverage of 298 reads at that position.
Position Sequence
platform
Data processing pipeline
1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
HA.170
T!A
1 ND/935 <1% ND/2191 <1% ND/1348 <1%
2 ND/300 <1% 11/693 1,59% ND/551 <1%
3 ND/82� <1%� ND/245� <1%� ND/210� <1%�
HA.170
T!C
1 ND/935 <1% ND/2191 <1% ND/1348 <1%
2 ND/300 <1% 18/693 2,60% ND/551 <1%
3 ND/82� <1%� ND/245� <1%� ND/210� <1%�
HA.171
C!A
1 ND/931 <1% ND/2184 <1% ND/1339 <1%
2 ND/323 <1% 12/698 1,72% ND/558 <1%
3 ND/82� <1%� ND/245� <1%� ND/210� <1%�
HA.194
C!A
1 ND/991 <1% ND/2397 <1% ND/1455 <1%
2 ND/353 <1% 22/701 3,14% ND/553 <1%
3 ND/58� <1%� ND/250� <1%� ND/212� <1%�
HA.195
C!A
1 ND/995 <1% ND/2390 <1% ND/1464 <1%
2 ND/356 <1% 20/701 2,85% ND/553 <1%
3 ND/55� <1%� ND/250� <1%� ND/212� <1%�
HA.268
C!T
1 ND/1140 <1% ND/2580 <1% ND/1626 <1%
2 ND/1293 <1% 25/1563 1,60% ND/1338 <1%
3 ND/88� <1%� ND/252� <1%� ND/212� <1%�
HA.272
A!T
1 ND/1156 <1% ND/2593 <1% ND/1639 <1%
2 17/1424 1,19% 20/1563 1,28% ND/1404 <1%
3 ND/81� <1%� ND/253� <1%� ND/213� <1%�
HA.407
G!T
1 ND/1144 <1% ND/2364 <1% ND/1553 <1%
2 ND/1773 <1% 31/2121 1,46% ND/1855 <1%
3 ND/74� <1%� ND/237� <1%� ND/212� <1%�
HA.407
G!A
1 ND/1144 <1% 27/2364 1,14% ND/1553 <1%
2 ND/1773 <1% ND/2121 <1% ND/1856 <1%
3 ND/74� <1%� ND/237� <1%� ND/212� <1%�
HA.418
A!G
1 ND/1111 <1% ND/2319 <1% ND/1492 <1%
2 29/2195 1,32% 38/2513 1,51% ND/2197 <1%
3 ND/69� <1%� ND/237� <1%� ND/212� <1%�
HA.453
T!G
1 ND/1339 <1% 29/2736 1,06% ND/1811 <1%
2 ND/2342 <1% ND/2695 <1% ND/2384 <1%
3 ND/91� <1%� ND/193� <1%� ND/179� <1%�
HA.560
A!G
1 43/1587 2,71% 113/3385 3,34% 55/1517 3,63%
2 56/2397 2,34% 145/2912 4,98% 113/2495 4,53%
3 21/884 2,38% 72/1754 4,10% 43/1245 3,45%
HA.715
C!T
1 ND/1663 <1% 62/3832 1,62% 24/1582 1,52%
2 26/2283 1,14% 55/2722 2,02% 50/2420 2,07%
3 ND/531 <1% 20/1883 1,06% 15/1245 1,20%
HA.867
C!T
1 59/1533 3,85% 206/3183 6,47% 104/1537 6,77%
2 59/2031 2,90% 150/2525 5,94% 127/2253 5,64%
3 11/180 6,11% 48/647 7,42% 28/385 7,27%
(Continued)
Comparison of sequencing methods and data processing pipelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0229326 February 20, 2020 17 / 28
Table 4. (Continued)
Position Sequence
platform
Data processing pipeline
1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
HA.963
T!C
1 122/1401 8,71% 446/3071 14,52% 189/1419 13,32%
2 90/1517 5,93% 318/2189 14,53% 247/1828 13,51%
3 5/69 7,25% 107/606 17,66% 47/293 16,04%
HA.1000
A!C
1 ND/1409 <1% 48/2962 1,62% ND/1873 <1%
2 ND/1629 <1% ND/1919 <1% ND/1645 <1%
3 ND/84� <1%� ND/614 <1% ND/293� <1%�
HA.1177
G!A
1 ND/1222 <1% ND/2224 <1% ND/1597 <1%
2 ND/1652 <1% 34/1901 1,79% ND/1724 <1%
3 ND/289� <1%� ND/549 <1% ND/270 <1%
HA.1183
A!G
1 ND/1210 <1% ND/2226 <1% ND/1589 <1%
2 ND/1770 <1% ND/1892 <1% ND/1723 <1%
3 ND/280� <1%� 6/547 1,10% ND/268� <1%�
HA.1199
T!G
1 ND/1182 <1% ND/2124 <1% ND/1518 <1%
2 ND/1615 <1% 27/1899 1,42% ND/1732 <1%
3 ND/296� <1%� ND/545 ND/266� <1%�
HA.1263
A!G
1 16/963 1,66% 57/1841 3,10% 26/954 2,73%
2 26/1924 1,35% 56/2207 2,54% 41/1967 2,08%
3 ND/1161 <1% 63/2226 2,83% 33/1350 2,44%
HA.1430
A!G
1 ND/1311 <1% ND/2870 <1% ND/1827 <1%
2 ND/1498 <1% 36/1924 1,87% ND/1659 <1%
3 ND/955 <1% ND/2391 <1% ND/1452 <1%
HA.1455
C!T
1 ND/1333 <1% ND/2753 <1% 14/1233 1,14%
2 ND/1846 <1% ND/2242 <1% ND/1895 <1%
3 ND/1093 <1% ND/2373 <1% ND/1449 <1%
HA.1543
A!G
1 25/1209 2,07% 94/2757 3,41% 37/1142 3,24%
2 ND/1660 <1% 56/1857 3,02% 41/1585 2,59%
3 ND/1182 <1% ND/3324 <1% ND/1972 <1%
HA.1624
C!A
1 ND/998 <1% ND/2174 <1% ND/1478 <1%
2 ND/1173 <1% 25/1291 1,94% ND/1120 <1%
3 ND/2218 <1% ND/3654 <1% ND/2244 <1%
HA.1634
C!A
1 ND/930 <1% ND/2032 <1% ND/1388 <1%
2 ND/1091 <1% 16/1218 1,31% ND/1048 <1%
3 ND/2616 <1% ND/3704 <1% ND/2269 <1%
HA.1638
C!A
1 ND/932 <1% ND/1991 <1% ND/1368 <1%
2 ND/1083 <1% 15/1180 1,27% ND/1010 <1%
3 ND/2600 <1% ND/3709 <1% ND/2276 <1%
HA.1643
T!A
1 ND/875 <1% ND/1892 <1% ND/1291 <1%
2 ND/1028 <1% 13/1110 1,17% ND/944 <1%
3 ND/2612 <1% ND/3703 <1% ND/2278 <1%
HA.1643
T!G
1 ND/875 <1% ND/1892 <1% ND/1291 <1%
2 ND/1028 <1% 12/1110 1,08% ND/944 <1%
3 ND/2612 <1% ND/3703 <1% ND/2278 <1%
(Continued)
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SP3 data but this might be due to the fact that many positions identified in SP3 data did not
meet the minimum coverage criteria and were therefore discarded.
For brevity, the detailed results for the HA gene segment of the DETU virus are shown in
Table 4. This virus segment was chosen because it showed the best reproducibility of results
for�5% minority variants in all SP/DPP combinations. In the DETU HA segment, 33 posi-
tions containing a mSNV occurring in�1% of reads with sufficient coverage (�298 reads)
were identified. Only 3 of these positions (9%) were identified in all SP/DPP combinations.
The majority of the positions (25/33, 76%) were only identified in one of the nine SP/DPP
combinations. However, it needs to be noted that the SP3 data coverage was insufficient in
all three DPPs to detect�1% variants for 11 of those positions (Table 4).
Although a comparison between the frequencies of the detected mSNVs might be appropri-
ate, based on these results where even absence vs. presence of the mSNVs is poorly comparable
further in-depth analyses on these frequencies is not performed because of its limited value.
Determining the influence of the minor variant detection method. To isolate the effect
of just the mSNV identification step in the DPP, independent of the alignment step, quality-
trimmed alignment files (�.bam files) of the data (subdivided per virus, per SP and per DPP)
were shared and subjected to the same DPP mSNV detection process (in this case DPP3) and
compared to the original outcomes from DPP1 and DPP2 (Table 5). In the majority of posi-
tions, the different mSNV identification processes did not influence the results, as 84% (119/
142) of the mSNVs were identified regardless of the mSNV identification process. Twenty-
three mSNVs that were not reproduced by DPP3 mSNV identification analysis, were repro-
duced when the ‘Direction and position Filters’ in DPP3 were ignored (Table 5, marked with #
of ##). These parameters filter out mSNVs when the set criteria for the read direction (variant
must occur in both forward and reverse reads), relative read direction (statistical approach of
Table 4. (Continued)
Position Sequence
platform
Data processing pipeline
1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
HA.1691
G!A
1 ND/596 <1% ND/1110 <1% 7/404 1,73%
2 ND/767 <1% ND/873 <1% ND/696 <1%
3 ND/2499 <1% ND/3575 <1% ND/2222 <1%
HA.1693
A!T
1 ND/582 <1% ND/1081 <1% 7/391 1,79%
2 ND/751 <1% ND/864 <1% ND/690 <1%
3 ND/2310 <1% ND/3569 <1% ND/2219 <1%
HA.1695
T!C
1 ND/555 <1% ND/1030 <1% 7/366 1,91%
2 ND/779 <1% ND/3557 <1% ND/688 <1%
3 ND/1767 <1% ND/3557 <1% ND/2220 <1%
HA.1698
C!T
1 ND/537 <1% ND/977 <1% ND/601 <1%
2 ND/758 <1% 11/852 1,29% ND/681 <1%
3 ND/2260 <1% ND/3520 <1% ND/2113 <1%
HA.1705
A!G
1 ND/492 <1% ND/883 <1% ND/528 <1%
2 ND/733 <1% 11/832 1,32% ND/660 <1%
3 ND/1709 <1% ND/3300 <1% ND/2016 <1%
Positions with a too low coverage (<298 reads/position) to detect�1% variants are marked with an asterisk (�).
Numbers are displayed as [number of variants]/[number of reads on that position]. ND: not detected.
https://doi.org/10.1371/journal.pone.0229326.t004
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Table 5. The reproducibility of positions with at least one�5% variant when alignment files from the respective DPPs are all uploaded into DPP3 for only the
mSNV identification process versus when the mSNV identifications are fully performed by the respective DPPs.
Virus Position Sequence
platform
Data Processing pipeline Bam file generating processing pipeline
1 2 3 1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
NLCH PB2.1879
G!A
1 81/1301 6,2% 246/2716 9,1% 112/1203 9,3% 132/1375 9,6% 246/2716 9,1% 121/1301 9,3%
2 47/956 4,9% 117/1137 10,3% 114/1064 10,7% 119/1122 10,6% 117/1137 10,3% 114/1064 10,7%
3 49/530 9,2% 131/1341 9,8% 129/1338 9,6% 54/542 10,0% 131//1341 9,8% 129/1338 9,6%
PB2.2101
G!A
1 53/1118 4,7% 261/2704 9,7% 110/897 12,3% 138/1180 11,7% 261/2704 9,7% 121/1086 11,1%
2 21/1578 1,3% 125/1875 6,7% 121/1463 8,3% ND/1856## <1% ND/1850# <1% 121/1463 8,3%
3 13/542 2,4% 199/1433 13,9% 199/1435 13,9% 87/625 13,9% 199/1433 13,9% 199/1435 13,9%
PB2.2277
T!G
1 ND/479 <1% 86/1008 8,5% 33/190 17,4% ND/849 <1% ND/1008## <1% 37/281 13,2%
2 ND/557 <1% ND/623 <1% ND/534 <1% ND/619 <1% ND/623 <1% ND/534 <1%
3 ND/680 <1% ND/1117 <1% ND/1024 <1% ND/708 <1% ND/1117 <1% ND/1027 <1%
PB1.87 A!G 1 ND/818 <1% ND/1754 <1% ND/1114 <1% ND/1264 <1% ND/1753 <1% ND/1114 <1%
2 25/230 10,9% ND/376 <1% ND/328 <1% ND/368## <1% ND/376 <1% ND/328 <1%
3 ND/275 <1% ND/537 <1% ND/537 <1% ND/278 <1% ND/537 <1% ND/537 <1%
PB1.2240
G!C
1 ND/664 <1% 54/1341 4,0% 38/418 9,1% ND/1004 <1% ND/1341# <1% 46/486 9,5%
2 ND/1231 <1% ND/1271 <1% ND/1233 <1% ND/1277 <1% ND/1271 <1% ND/1235 <1%
3 ND/161 <1% ND/277 <1% ND/276 <1% ND/163 <1% ND/277 <1% ND/276 <1%
PB1.2268
A!G
1 ND/336 <1% 29/641 4,5% 11/176 6,3% 15/322� 4,66%� 37/641 5,8% 13/213 6,1%
2 ND/993 <1% ND/1026 <1% ND/1002 <1% ND/1025 <1% ND/1026 <1% ND/1002 <1%
3 ND/53 <1% ND/159 <1% ND/148 <1% ND/90 <1% ND/159 <1% ND/151 <1%
PA.2167
T!G
1 ND/141 <1% ND/288 <1% ND/154 <1% ND/235 <1% 21/288� 7,29%� ND/154 <1%
2 ND/757 <1% ND/807 <1% ND/773 <1% ND/812 <1% ND/807 <1% ND/733 <1%
3 ND/704 <1% ND/1070 <1% ND/1077 <1% ND/714 <1% ND/1070 <1% ND/1078 <1%
HA.104
A!G
1 ND/733 <1% ND/1761 <1% ND/1151 <1% ND/1175 <1% ND/1761 <1% ND/1135 <1%
2 ND/437 <1% ND/1370 <1% ND/1156 <1% ND/1326 <1% ND/1369 <1% ND/1142 <1%
3 ND/1 <1% ND/105 <1% 12/105 11,4% ND/6 <1% ND/105 <1% 12/105 11,4%
HA.1689
T!C
1 ND/390 <1% ND/694 <1% 11/217 5,1% ND/610 <1% ND/694 <1% 13/260 5,0%
2 ND/2018 <1% ND/4083 <1% ND/3979 <1% ND/4045 <1% ND/4081 <1% ND/3979 <1%
3 ND/937 <1% ND/1669 <1% ND/1680 <1% ND/1106 <1% ND/1669 <1% ND/1680 <1%
NA.3 T!C 1 ND/32 <1% ND/105 <1% ND/49 <1% ND/92 <1% 7/105� 6,67%� ND/49 <1%
2 ND/6 <1% ND/313 <1% ND/297 <1% ND/305 <1% ND/313 <1% ND/297 <1%
3 ND/2 <1% ND/25 <1% ND/25 <1% ND/6 <1% ND/25 <1% ND/25 <1%
NP.105 A!G 1 ND/182 <1% ND/449 <1% ND/343 <1% ND/374 <1% 6/449� 1,34%� ND/343 <1%
2 83/1507 5,5% ND/1890 <1% ND/1804 <1% ND/1866## <1% ND/1890 <1% ND/1805 <1%
3 ND/89 <1% ND/704 <1% ND/702 <1% ND/246 <1% ND/704 <1% ND/703 <1%
NP.1239
A!T
1 32/2428 1,3% 279/5410 5,2% ND/3092 <1% ND/3372## <1% ND/5410# <1% ND/3092 <1%
2 ND/2345 <1% ND/2643 <1% ND/2453 <1% ND/2626 <1% ND/2643 <1% ND/2453 <1%
3 ND/1711 <1% ND/2111 <1% ND/2117 <1% ND/1712 <1% ND/2111 <1% ND/2117 <1%
NP.1489
G!A
1 ND/182 <1% 26/336 7,7% ND/172 <1% ND/242 <1% 26/376� 6,9% ND/172 <1%
2 ND/436 <1% ND/452 <1% ND/444 <1% ND/451 <1% ND/451 <1% ND/444 <1%
3 ND/1320 <1% ND/1799 <1% ND/1799 <1% ND/1325 <1% ND/1799 <1% ND/1799 <1%
NS.827 C!T 1 ND/249 <1% 19/419 4,5% ND/205 <1% ND/365 <1% 21/412 5,3% ND/205 <1%
2 ND/1316 <1% ND/1423 <1% ND/1375 <1% ND/1427 <1% ND/1422 <1% ND/1375 <1%
3 ND/2091 <1% ND/2901 <1% ND/2757 <1% ND/2293 <1% ND/2898 <1% ND/2929 <1%
NS829 G!T 1 ND/221 <1% 19/380 5,0% ND/179 <1% ND/328 <1% 19/376 5,4% ND/179 <1%
2 ND/1302 <1% ND/1391 <1% ND/1341 <1% ND/1388 <1% ND/1389 <1% ND/1341 <1%
3 ND/2117 <1% ND/2852 <1% ND/2727 <1% ND/2279 <1% ND/2852 <1% ND/2880 <1%
NS.833 A!T 1 ND/187 <1% ND/287 <1% 5/88 5,7% ND/259 <1% 11/257� 4,28%� 5/96 5,2%
2 ND/1224 <1% ND/1327 <1% ND/1284 <1% ND/1314 <1% ND/1322 <1% ND/1284 <1%
3 ND/1367 <1% ND/2430 <1% ND/2333 <1% ND/1779 <1% ND/2430 <1% ND/2360 <1%
(Continued)
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Table 5. (Continued)
Virus Position Sequence
platform
Data Processing pipeline Bam file generating processing pipeline
1 2 3 1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
DETU PB2.900
A!G
1 38/1335 2,9% 136/2740 5,0% 61/1231 5,0% 68/1328 5,12 136/2740 4,96 65/1322 4,92
2 35/1645 2,1% 77/1800 4,3% 66/1629 4,1% 70/1775 4,0% 77/1800 4,3% 66/1629 4,1%
3 30/861 3,5% 86/2308 3,7% 47/1245 3,8% ND/1001## <1% ND/2308# <1% 47/1245 3,8%
PB2.1054
T!C
1 69/1369 5,0% 168/2637 6,4% 97/1304 7,4% 105/1393 7,5% 168/2637 6,4% 100/1376 7,3%
2 60/1477 4,1% 115/1836 6,3% 99/1605 6,2% 113/1810 6,2% 115/1836 6,3% 99/1605 6,2%
3 6/392 1,5% 94/2038 4,6% 48/1054 4,6% 32/524 6,1% 94/2038 4,6% 48/1054 4,6%
PB2.2257
A!C
1 ND/867 <1% ND/1563 <1% 24/463 5,2% ND/1447 <1% ND/1562 <1% 26/472 5,5%
2 ND/531 <1% ND/581 <1% ND/378 <1% ND/588 <1% ND/580 <1% ND/378 <1%
3 ND/893 <1% ND/2286 <1% ND/1346 <1% ND/1341 <1% ND/2185 <1% ND/1347 <1%
PB2.2277
T!G
1 ND/644 <1% 52/1150 4,5% 27/307 8,8% ND/1062 <1% ND/1150# <1% 28/381 7,4%
2 ND/418 <1% ND/472 <1% ND/284 <1% ND/474 <1% ND/472 <1% ND/284 <1%
3 ND/1208 <1% ND/1948 <1% ND/1209 <1% ND/1251 <1% ND/1948 <1% ND/1214 <1%
PB1.14 C!T 1 ND/144 <1% 48/433 11,1% ND/239 <1% ND/362 <1% 48/433 11,1% ND/239 <1%
2 ND/90 <1% ND/355 <1% ND/304 <1% ND/345 <1% ND/351 <1% ND/304 <1%
3 ND/562 <1% ND/792 <1% ND/496 <1% ND/633 <1% ND/655 <1% ND/504 <1%
PB1.23 T!G 1 ND/207 <1% 30/535 5,6% ND/315 <1% ND/470 <1% 30/535 5,6% ND/315 <1%
2 ND/103 <1% ND/365 <1% ND/319 <1% ND/365 <1% 4/365� 1,96%� ND/319 <1%
3 ND/699 <1% ND/950 <1% ND/609 <1% ND/702 <1% ND/950 <1% ND/609 <1%
PB1.87 A!G 1 ND/744 <1% ND/1644 <1% ND/1076 <1% ND/1218 <1% ND/1644 <1% ND/1076 <1%
2 49/365 13,4% ND/677 <1% ND/576 <1% 13/638 2,0% ND/674 <1% ND/576 <1%
3 ND/721 <1% ND/1156 <1% ND/793 <1% ND/731 <1% ND/1156 <1% ND/793 <1%
PB1.2240
G!C
1 ND/757 <1% 23/1517 1,5% 26/515 5,0% ND/1266 <1% ND/1515# <1% 28/631 4,4%
2 ND/944 <1% ND/985 <1% ND/806 <1% ND/994 <1% ND/984 <1% ND/806 <1%
3 ND/274 <1% ND/439 <1% ND/253 <1% ND/301 <1% ND/439 <1% ND/253 <1%
PB1.2268
A!G
1 5/470 1,1% 33/928 3,6% 22/278 7,9% 28/420 6,7% ND/928## <1% 23/354 6,5%
2 ND/798 <1% ND/829 <1% ND/671 <1% ND/839 <1% ND/829 <1% ND/671 <1%
3 ND/109 <1% ND/259 <1% ND/123 <1% ND/193 <1% ND/259 <1% ND/126 <1%
PB1.2271
A!G
1 12/446 2,7% 59/901 6,5% 16/263 6,1% 29/413 7,0% 59/901 6,6% 21/336 6,3%
2 ND/729 <1% 47/810 5,8% 40/649 6,2% 43/750� 5,73%� 47/810 5,8% 40/649 6,2%
3 1/32 3,1% ND/123 <1% 2/83 2,4% 5/75 6,7% 5/124� 4,03%� 2/83 2,4%
HA.867
C!T
1 59/1533 3,8% 206/3183 6,5% 104/1537 6,8% 112/1584 7,1% 206/3183 6,5% 109/1573 6,9%
2 59/2031 2,9% 150/2525 5,9% 127/2253 5,6% 144/2502 5,8% 150/2525 5,9% 127/2253 5,6%
3 11/180 6,1% 48/647 7,4% 28/385 7,3% 13/182 7,1% 48/647 7,4% 28/385 7,3%
HA.963
T!C
1 122/1401 8,7% 446/3071 14,5% 189/1419 13,3% 200/1468 13,6% 446/3071 14,5% 193/1455 13,3%
2 90/1517 5,9% 318/2189 14,5% 247/1828 13,5% 308/2165 14,2% 318/2189 14,5% 247/1828 13,5%
3 5/69 7,2% 107/606 17,7% 47/293 16,0% 12/81 14,8% 107/606 17,7% 47/293 16,0%
NP.1491
C!A
1 ND/278 <1% 71/583 12,2% ND/206 <1% ND/390 <1% ND/579# <1% ND/206 <1%
2 ND/723 <1% ND/769 <1% ND/692 <1% ND/766 <1% ND/769 <1% ND/692 <1%
3 ND/799 <1% ND/2031 <1% ND/1206 <1% ND/858 <1% ND/2031 <1% ND/1206 <1%
NA.65 T!C 1 19/503 3,8% 52/1229 4,2% 16/467 3,4% 22/535 4,1% 52/1229 4,2% 20/540 3,7%
2 20/662 3,0% 50/1104 4,5% 45/992 4,5% 52/1063 4,9% 50/1104 4,5% 45/992 4,5%
3 24/557 4,3% 53/1099 4,8% 37/727 5,1% 28/584 4,8% 53/1099 4,8% 37/727 5,1%
NA.78 T!C 1 23/599 3,8% 57/1403 4,1% 20/557 3,6% 23/622 3,7% 57/1403 4,1% 24/638 3,8%
2 21/692 3,0% 55/1147 4,8% 50/1033 4,8% 54/1109 4,9% 55/1147 4,8% 50/1033 4,8%
3 23/580 4,0% 51/1124 4,5% 37/735 5,0% 27/585 4,6% ND/1124# <1% 37/735 5,0%
NA.89 T!C 1 23/713 3,2% 55/1670 3,3% 22/651 3,4% 26/731 3,6% 55/1670 3,3% 26/751 3,5%
2 23/798 2,9% 56/1261 4,4% 50/1134 4,4% 54/1224 4,4% 56/1261 4,4% 50/1134 4,4%
3 24/580 4,1% 55/1196 4,6% 40/775 5,2% 28/587 4,8% 55/1196 4,6% 40/775 5,2%
NA.117 T!C 1 37/908 4,1% 87/2140 4,1% 36/818 4,4% 40/914 4,4% 87/2140 4,7% 43/922 4,7%
2 28/1102 2,5% 67/1631 4,1% ND/1459 <1% 70/1586 4,4% 67/1631 4,1% ND/1459 <1%
3 22/531 4,1% 57/1276 4,5% 42/812 5,2% 28/544 5,2% ND/1276# <1% 42/812 5,2%
NA.126 T!C 1 37/983 3,8% 83/2294 3,6% 36/876 4,1% 39/973 4,0% 83/2294 3,6% 43/981 4,4%
2 31/1126 2,8% 72/1676 4,3% 65/1502 4,3% 75/1616 4,6% 72/1676 4,3% 65/1502 4,3%
3 26/519 5,0% 62/1395 4,4% 43/812 5,3% 30/537 5,6% 62/1395 4,4% 43/812 5,3%
(Continued)
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forward/reverse balance) and read position (removal of systemic errors) are not met. However,
DPP1 and DPP2 contain similar quality parameters in their mSNV identification process,
indicating that different DPPs deal differently with quality parameters, and data could be
excluded or included based on the DPP used. In addition, 9 additional mSNVs were identified
in the �.bam files compared to the original mSNV outputs. It needs to be noted that the cover-
age of SP data analysed by DPP1 for positions identified with mSNVs was considerably lower
compared to the coverage at that position in the input �.bam files, suggesting additional quality
filtering in the mSNV detection step of DPP1. However, the influence on mSNV identification
was limited most likely due to the initial high nucleotide coverage.
To better visualise the differences in coverages and allele counts a graphical display of the
data for four positions showing mSNVs in different frequencies for each SP/DPP combination
is included in S2 Fig. In general, SNVs were rarely missed due to low coverage, as also high
coverage SP/DPP combinations display discrepancies (Tables 3 and 4).
Discussion
NGS data are used for different applications. Although sequence technologies and the accom-
panying analysis tools are subjected to rapid development, a lot of follow-up research is based
Table 5. (Continued)
Virus Position Sequence
platform
Data Processing pipeline Bam file generating processing pipeline
1 2 3 1 2 3
Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage Minor
variants
Percentage
UKDD PB2.2277
T!G
1 ND/415 <1% 28/507 5,5% ND/475 <1% ND/503 <1% ND/507# <1% ND/475 <1%
2 ND/589 <1% ND/620 <1% ND/601 <1% ND/627 <1% ND/620 <1% ND/601 <1%
3 ND/1140 <1% ND/1996 <1% ND/2065 <1% ND/1186 <1% ND/1996 <1% ND/2071 <1%
PB2.2278
T!G
1 ND/367 <1% ND/471 <1% ND/464## <1% ND/465 <1% ND/471 <1% 17/268 6,3%
2 ND/581 <1% ND/613 <1% ND/581 <1% ND/621 <1% ND/588 <1% ND/581 <1%
3 ND/1141 <1% ND/1985 <1% ND/1993 <1% ND/1184 <1% ND/1975 <1% ND/2004 <1%
PB1.87 A!G 1 ND/387 <1% ND/440 <1% ND/439 <1% ND/451 <1% ND/417 <1% ND/439 <1%
2 26/327 8,0% 32/395 8,1% ND/351 <1% 33/385 8,6% ND/395# <1% ND/351 <1%
3 ND/617 <1% ND/1133 <1% ND/1136 <1% ND/622 <1% ND/1133 <1% ND/1136 <1%
PB1.728
C!A
1 ND/750 <1% ND/832 <1% ND/836 <1% ND/853 <1% ND/832 <1% ND/836 <1%
2 ND/776 <1% 52/928 5,6% ND/829 <1% ND/888 <1% ND/912## <1% ND/829 <1%
3 ND/2459 <1% ND/4290 <1% ND/4293 <1% ND/2471 <1% ND/4287 <1% ND/4292 <1%
PB1.730
C!T
1 ND/742 <1% ND/824 <1% ND/826 <1% ND/844 <1% ND/824 <1% ND/826 <1%
2 ND/767 <1% 57/1008 5,7% ND/832 <1% ND/893 <1% ND/1008# <1% ND/832 <1%
3 ND/2339 <1% ND//4286 <1% ND/4289 <1% ND/2464 <1% ND/4285 <1% ND/4284 <1%
PB1.883
G!C
1 ND/942 <1% ND/997 <1% ND/997 <1% ND/1016 <1% ND/997 <1% ND/997 <1%
2 ND/1689 <1% ND/1856 <1% ND/1760 <1% ND/1867 <1% ND/1856 <1% ND/1760 <1%
3 ND/2479 <1% 47/690 6,8% ND/3681 <1% ND/2635 <1% ND/690## <1% ND/3697 <1%
PA.49 G!C 1 ND/103 <1% 6/117 5,1% ND/115 <1% ND/113 <1% ND/117# <1% ND/115 <1%
2 ND/337 <1% ND/435 <1% ND/392 <1% ND/441 <1% ND/434 <1% ND/392 <1%
3 ND/111 <1% ND/207 <1% ND/204 <1% ND/113 <1% ND/206 <1% ND/206 <1%
PA.82 C!T 1 ND/155 <1% ND/180 <1% ND/177 <1% ND/179 <1% ND/180 <1% ND/177 <1%
2 ND/695 <1% ND/809 <1% ND/745 <1% ND/797 <1% ND/809 <1% ND/745 <1%
3 ND/64 <1% ND/247 <1% 30/248 12,1% ND/74 <1% ND/247 <1% 30/248 12,1%
NS.811 G!T 1 ND/221 <1% 17/270 6,3% ND/249 <1% ND/261 <1% ND/270# <1% ND/249 <1%
2 ND/2452 <1% ND/2725 <1% ND/2557 <1% ND/2742 <1% ND/2725 <1% ND/2557 <1%
3 ND/3117 <1% ND/4125 <1% ND/4139 <1% ND/3188 <1% ND/4124 <1% ND/4142 <1%
�Locations containing mSNV detections in the DPP3 mSNV analysis of the bam files but not in the original DPPs; Locations containing�1% mSNVs that could be
reproduced by deleting DPP3s default ‘Direction and position filters’ with those exactly reproduced (#) and those approximately reproduced but with different
coverages and/or variants (##).
https://doi.org/10.1371/journal.pone.0229326.t005
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on initial findings. Accuracy and repeatability are key values for proper scientific research but
the impact of NGS results also reaches beyond science to clinical settings where important
clinical management and treatment decisions are based on such results. In this study the com-
parability of NGS data analyses were analysed using identical input material per virus but dif-
ferent laboratory workflows from nucleic acid extraction and sequencing to data analysis. In
addition, the COMPARE “Data Hub” platform was tested for the purpose of sharing large raw
datafiles between institutions in an outbreak situation. Using this platform, raw sequence data
files up to the size of 8 Gigabytes, alignment files and metadata files of three influenza A/H5N8
viruses were successfully shared in real-time among 3 institutions to allow independent
sequencing and analysis procedures, including mSNV identification, to be performed. The
Data Hub is available to all institutions.
The aim of this study was to determine how comparable consensus and minority variant
results were between laboratories performing their standard analyses, and whether discrepan-
cies could be attributed to the SP, DPP or a combination of both. With the lack of a ground
truth/gold standard, all data obtained were compared amongst each other. Importantly, reli-
able consensus sequences were generated independently of the SP/DPP combination used,
although the well-known artefactual InDels in homopolymer regions in SP3 (Roche 454
genome sequencer) sequence data required manual editing. Such consensus sequences rou-
tinely form the basis for a detailed characterization of the influenza strain in an outbreak situa-
tion, as they are used for the prediction of pathogenicity and pandemic potential of influenza
strains.
In contrast to the reproducible generation of consensus genome sequences, the hypothesis
that minority variants could be identified reproducibly has to be rejected. The observed differ-
ences were mainly attributed to the alignment processes in the different DPPs. The interpreta-
tion of minority variant analysis thus needs a different level of careful standardization and
awareness about the possible limitations as shown in this study. Reproducibility of mSNV
results appeared to be influenced by both the different SPs (resulting in different sequence
depths Fig 2) and DPPs (resulting in differences in alignment and mSNV identification of the
same input data, Fig 2 and Table 5). There was limited reproducibility of mSNV identification
data, even for relative high frequency mSNVs. As expected, the reproducibility was best (30%)
for mSNVs occurring in high frequency (�10%), and least for the low frequent (�1%) mSNVs
(9.4% to 31.1%). Also, the number of positions with 1–5% mSNVs (with sufficient coverage)
was much higher (250 in SP1 data, 213 in SP2 data, and 45 in SP3 data) than the number of
positions with>5–10% mSNVs (n = 27) or >10% mSNVs (n = 10).
The set-up of this study allowed many variables to influence the final result. The differences
from first laboratory procedures and sample preparations up to the final analysis methods can
all have contributed to the observed differences in mSNV identification. At this level, especially
with lacking an NGS gold standard, it becomes difficult to determine which identified mSNVs
are ‘true variants’ and which could be due to systematic errors introduced by RNA isolation
methods, amplification, sequencing or manipulated by data processing pipeline settings.
Unsurprisingly, the results of this study imply that the choice of SP influences the final output,
but the results from this study also indicate that the DPP, especially the alignment process,
influences coverage. The SP and DPP derived differences in coverage are of importance
because up to a certain (currently unknown, probably SP/DPP dependent) threshold, a higher
coverage will provide a more reliable result about the presence of mSNVs. Although the aim
of this study was to explicitly compare the three institutions own standard workflows, some
parameters (like the phred score and detection limit) were synchronized between the different
DPPs. Moreover, the data from each SP were re-processed in each DPP. However, all DPPs
use different underlying algorithms and interpret the set parameters differently which might
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all contribute to the observed differences. These results are partly in line with previous research
that showed the need of NGS result validation and concluded that only those mSNVs with a
coverage>100 and a frequency of>40% could be identified by NGS methods without second-
ary confirmation [32], however, this conclusion was based on using the same sample prepara-
tion method within a single laboratory. Another recent study sets the cut-off for intrahost
virus diversity at 3% with input of at least 1000 RNA copies and a read depth of at least 400x at
each genome position for Illumina sequencing [33].
Although some studies have been published on SP error rates [34–37] and PCR amplifica-
tion induced variants [38–41], a gold standard system for mSNV analysis is lacking. In addi-
tion, the DPPs can alter the data due to elimination or inclusion of certain sequences based
on the set quality parameters. Allowing too many low-quality reads or being too stringent
on the data will influence the coverage per position and might also influence the accuracy of
the mSNV identification rate, especially when the coverage is low [42, 43]. Although a low
comparability of mSNVs identified in the different SP and DPP combinations was observed,
it can be concluded that 454 (SP3) sequencing has approximately the same accuracy as Illu-
mina (SP1 and 2) sequencing based on the number and percentage of reproducible mSNVs
in this dataset when ignoring InDel errors in homopolymer regions. Although, Roche 454
sequencing machines are no longer in production, it added value to include 454 sequencing
as an alternative sequence platform with alternative chemistry to Illumina. In addition,
because Roche 454 was the first commercially successful next generation sequencing system,
it was used in research that served as a fundament for follow-up studies [44]. A comparison
of Illumina with newer third or fourth generation sequencing platforms (e.g. Nanopore or
Pac Bio) would be interesting in the future. However, the overall error rate remains higher
than the shorter read technologies and recent work concludes that these new platforms are
currently not suitable for the detection of minor variants [33]. In addition, it would be inter-
esting to compare mSNV results of SPs outputting small sequence reads (like Illumina, 454
and Ion Torrent) to new sequencing techniques that output full-length sequence data (e.g.
Nanopore [45]). The latter might be less vulnerable to quality trimming parameters com-
pared to small reads and might provide a more consistent nucleotide coverage over complete
gene segment.
For mSNV analyses by different labs, very stringent SP/DPP protocols need to be evalu-
ated, for instance by cross-validating results. To allow a better comparison it would be rec-
ommended to create some kind of gold standard by for instance evaluating parameters
based on sequencing of technical replicates, and controlled mixes of clones. The mSNV anal-
ysis can be valuable for epidemiological tracing, to monitor early evolutionary events, or
drug resistance, possibly host adaptation, but this would require reproducibility of study
outcomes within and between laboratories. As this is currently not that case, more under-
standing of biases and errors generated by sample processing (enrichment procedures),
sequencing strategy (amplicons, shotgun), sequencing chemistry (each of which have their
own internal error rates) and the approach to data processing and analysis is needed. Under-
standing the parameters and thresholds in the software can be difficult and a systematic
study using a pipeline where the effect of changing each of these parameters both individu-
ally and in combination is required to determine the optimal settings for minor variant
analysis.
As alternate high-throughput sequencing technologies arise there will be a need to under-
stand inherent error profiles and how those are handled in data processing approaches. Cross-
validation should be supported by international proficiency tests on NGS techniques including
mSNV analyses that would be instrumental in validation of results and may foster the trust in
NGS-based diagnostics.
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Supporting information
S1 Table. PCR primers used in SP3 to cover the influenza A H5N8 gene segments.
(PDF)
S2 Table. SP/DPP overarching consensus sequences.
(PDF)
S3 Table. Number of raw sequences and influenza virus reads per SP per virus.
(PDF)
S1 File. DPP3 Sequence analysis protocol.
(PDF)
S1 Fig. Nucleotide coverage. The non-normalised nucleotide coverage displayed as number
of nucleotides per position for full genome sequences of the UKDD and DETU virus reads
mapped to the corresponding reference sequences. Panel A shows the coverage results for the
same SP dataset in the three different DPPs (DPP1: purple; DPP2: orange; DPP3 grey) for each
of the SP datasets. Panel B shows the coverage when the same DPP is used to analyse data from
the three different SPs (SP1: lilac; SP2: yellow; SP3:green) for each of the DPPs. The X-axis rep-
resents the position in the genome, the Y-axis represents the number of sequence reads per
position.
(TIF)
S2 Fig. Graphical display of the coverage and allele counts for four positions, showing
mSNVs in different frequencies for each SP/DPP combination. Arrows indicate the approx-
imate percentages in which the mSNVs were detected; 1–5% (orange), 5–10% (purple) and
>10% (green).
(TIF)
Acknowledgments
The authors would like to thank the staff of the European Nucleotide Archive and all technical
staff involved in the supporting laboratory and avian surveillance work.
Author Contributions
Data curation: Marjolein J. Poen, Anne Pohlmann, Saskia L. Smits, Richard J. Ellis.
Formal analysis: Marjolein J. Poen, Anne Pohlmann, Richard J. Ellis.
Funding acquisition: Ron A. M. Fouchier.
Investigation: Marjolein J. Poen.
Methodology: Theo M. Bestebroer, Claudia M. E. Schapendonk, Rachel D. Scheuer, Saskia L.
Smits.
Resources: Clara Amid.
Software: Clara Amid.
Supervision: Martin Beer, Ron A. M. Fouchier, Richard J. Ellis.
Writing – original draft: Marjolein J. Poen, Anne Pohlmann, Richard J. Ellis.
Writing – review & editing: Marjolein J. Poen, Anne Pohlmann, Sharon M. Brookes, Ian H.
Brown, Helen Everett, Martin Beer, Ron A. M. Fouchier, Richard J. Ellis.
Comparison of sequencing methods and data processing pipelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0229326 February 20, 2020 25 / 28
References
1. Heather J. and Chain B, The sequence of sequencers: The history of sequencing DNA. Genomics,
2016. 107(1): p. 1–8. https://doi.org/10.1016/j.ygeno.2015.11.003 PMID: 26554401
2. Van Dijk E, Auger H, Jaszczyszyn Y, Thermes C, Ten years of next-generation sequencing technology.
Trends Genet, 2014. 30(9): p. 418–26. https://doi.org/10.1016/j.tig.2014.07.001 PMID: 25108476
3. Ekblom R. and Galindo J., Applications of next generation sequencing in molecular ecology of non-
model organisms. Heredity (Edinb), 2011. 107(1): p. 1–15.
4. Ko¨ser C, Holden M, Ellington M, Cartwright E, Brown N, Ogilvy-Stuart A, et al., Rapid whole-genome
sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med, 2012. 366(24): p. 2267–75.
https://doi.org/10.1056/NEJMoa1109910 PMID: 22693998
5. Mellmann A, Harmsen D, Cummings C, Zentz E, Leopold S, Rico A, et al., Prospective genomic charac-
terization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next genera-
tion sequencing technology. PLoS One, 2011. 6(7): p. e22751. https://doi.org/10.1371/journal.pone.
0022751 PMID: 21799941
6. Leitner T, Halapi E, Scarlatti G, Rossi P, Albert J, Fenyo¨ E, et al., Analysis of heterogeneous viral popu-
lations by direct DNA sequencing. Biotechniques, 1993. 15(1): p. 120–7. PMID: 8363827
7. Tsiatis A, Norris-Kirby A, Rich R, Hafez M, Gocke C, Eshleman J, et al., Comparison of Sanger
sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnos-
tic and clinical implications. J Mol Diagn, 2010. 12(4): p. 425–32. https://doi.org/10.2353/jmoldx.2010.
090188 PMID: 20431034
8. Glenn T. Field guide to next-generation DNA sequencers. Mol Ecol Resour, 2011. 11(5): p. 759–69.
https://doi.org/10.1111/j.1755-0998.2011.03024.x PMID: 21592312
9. Li Y, Lei K, Kshatriya P, Gu, Jian, Ballesteros-Villagrana, et al., Ion Torrent™Next Generation
Sequencing–Detect 0.1% Low Frequency Somatic Variants and Copy Number Variations simulta-
neously in Cell-Free DNA. Thermo Fisher Scientific, 2017.
10. Schirmer M, D’Amore R, Ijaz U, Hall N, Quince C, Illumina error profiles: resolving fine-scale variation in
metagenomic sequencing data. BMC Bioinformatics, 2016. 17: p. 125. https://doi.org/10.1186/s12859-
016-0976-y PMID: 26968756
11. Lou DI, Hussman J, McBee J, Acevedo A, Andino R, Press W, et al., High-throughput DNA sequencing
errors are reduced by orders of magnitude using circle sequencing. Proc Natl Acad Sci U S A, 2013.
110(49): p. 19872–7. https://doi.org/10.1073/pnas.1319590110 PMID: 24243955
12. World Organisation for Animal Health, O.I.E., Update on highly pathogenic avian influenza in animals
(typeH5 and H7). 2014.
13. World Organisation for Animal Health, O.I.E., Update on highly pathogenic avian influenza in animals
(typeH5 and H7). 2015.
14. Hanna A, Banks J, Marston D, Ellis R, Brookes S, Brown I, Genetic Characterization of Highly Patho-
genic Avian Influenza (H5N8) Virus from Domestic Ducks, England, November 2014. Emerg Infect Dis,
2015. 21(5): p. 879–82. https://doi.org/10.3201/eid2105.141954 PMID: 25898126
15. Harder T, Maurer-Stroh S, Pohlmann A, Starick E, Ho¨reth-Bo¨ntgen D, Albrecht A, et al., Influenza
A(H5N8) Virus Similar to Strain in Korea Causing Highly Pathogenic Avian Influenza in Germany.
Emerg Infect Dis, 2015. 21(5): p. 860–3. https://doi.org/10.3201/eid2105.141897 PMID:
25897703
16. Bouwstra R, Heutink R, Bossers A, Harders F, Koch G, Elbers A, Full-Genome Sequence of Influ-
enza A(H5N8) Virus in Poultry Linked to Sequences of Strains from Asia, the Netherlands, 2014.
Emerg Infect Dis, 2015. 21(5): p. 872–4. https://doi.org/10.3201/eid2105.141839 PMID:
25897965
17. Verhagen J, Van Der Jeugd H, Nolet B, Slaterus R, Kharitonov S, De Vries P, et al., Wild bird surveil-
lance around outbreaks of highly pathogenic avian influenza A(H5N8) virus in the Netherlands, 2014,
within the context of global flyways. Euro Surveill, 2015. 20(12).
18. Poen M, Bestebroer T, Vuong O, Scheuer R, Van Der Jeugd H, Kleyheeg E, et al., Local amplification
of highly pathogenic avian influenza H5N8 viruses in wild birds in the Netherlands, 2016 to 2017. Euro
Surveill, 2018. 23(4).
19. Global Consortium for, H5N8 and Related Influenza Viruses, Role for migratory wild birds in the global
spread of avian influenza H5N8. Science, 2016. 354(6309): p. 213–217. https://doi.org/10.1126/
science.aaf8852 PMID: 27738169
20. Harrison P, Alako B, Amid C, Cerdeno-Ta´rraga A, Cleland I, Holt S, et al., The European Nucleotide
Archive in 2018. Nucleic Acids Research, 2019. 47(D1): p. D84–D88. https://doi.org/10.1093/nar/
gky1078 PMID: 30395270
Comparison of sequencing methods and data processing pipelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0229326 February 20, 2020 26 / 28
21. Karsch-Mizrachi I, Takagi T, Cochrane G, The international nucleotide sequence database collabora-
tion. Nucleic Acids Research, 2018. 46(D1): p. D48–D51. https://doi.org/10.1093/nar/gkx1097 PMID:
29190397
22. Amid C, Pakseresht N, Silvester N, Jayathilaka S, Lund O, Dynocski L, et al., The COMPARE Data
Hubs. bioRxiv, 2019: p. 555938.
23. Richard M, Herfst S, Van Den Brand J, Lexmond P, Bestebroer T, Rimmelzwaan G, et al., Low Viru-
lence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in
Ferrets. PLoS One, 2015. 10(6): p. e0129827. https://doi.org/10.1371/journal.pone.0129827 PMID:
26090682
24. Linster M, Van Boheemen S, De Graaf M, Schrauwen E, Lexmond P, Ma¨nz B, et al., Identification, char-
acterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell,
2014. 157(2): p. 329–339. https://doi.org/10.1016/j.cell.2014.02.040 PMID: 24725402
25. Li H, Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv, 2013.
26. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al., The Sequence Alignment/Map for-
mat and SAMtools. Bioinformatics, 2009. 25(16): p. 2078–9. https://doi.org/10.1093/bioinformatics/
btp352 PMID: 19505943
27. Zerbino D and Birney E, Velvet: algorithms for de novo short read assembly using de Bruijn graphs.
Genome Res, 2008. 18(5): p. 821–9. https://doi.org/10.1101/gr.074492.107 PMID: 18349386
28. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al., BLAST+: architecture
and applications. BMC Bioinformatics, 2009. 10: p. 421. https://doi.org/10.1186/1471-2105-10-421
PMID: 20003500
29. Hwang S, Kim E, Lee I, Marcotte E, Systematic comparison of variant calling pipelines using gold standard
personal exome variants. Sci Rep, 2015. 5: p. 17875. https://doi.org/10.1038/srep17875 PMID: 26639839
30. Hall T, BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows
95/98/NT. Nucleic Acids Symposium Series, 1999. 41: p. 95–98.
31. Dell R, Holleran S, Ramakrishnan R, Sample size determination. ILAR J, 2002. 43(4): p. 207–13.
https://doi.org/10.1093/ilar.43.4.207 PMID: 12391396
32. Mu W, Lu H, Chen J, Li S, Elliott A, Sanger Confirmation Is Required to Achieve Optimal Sensitivity and
Specificity in Next-Generation Sequencing Panel Testing. J Mol Diagn, 2016. 18(6): p. 923–932.
https://doi.org/10.1016/j.jmoldx.2016.07.006 PMID: 27720647
33. Grubaugh N, Gangavarapu K, Quick J, Matteson N, Goes De Jesus J, Main B, et al., An amplicon-
based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and
iVar. Genome Biol, 2019. 20(1): p. 8. https://doi.org/10.1186/s13059-018-1618-7 PMID: 30621750
34. Golan D and Medvedev P, Using state machines to model the Ion Torrent sequencing process and to
improve read error rates. Bioinformatics, 2013. 29(13): p. i344–51. https://doi.org/10.1093/
bioinformatics/btt212 PMID: 23813003
35. Manley L, Ma D, and Levine S, Monitoring Error Rates In Illumina Sequencing. J Biomol Tech, 2016. 27
(4): p. 125–128. https://doi.org/10.7171/jbt.16-2704-002 PMID: 27672352
36. Nakamura K, Oshima T, Morimoto T, Ikeda S, Yoshikawa H, Shiwa Y, et al., Sequence-specific error
profile of Illumina sequencers. Nucleic Acids Res, 2011. 39(13): p. e90. https://doi.org/10.1093/nar/
gkr344 PMID: 21576222
37. Shao W, Boltz V, Spindler J, Kearney M, Maldarelli F, Mellors J, et al., Analysis of 454 sequencing error
rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations
in HIV-1 DNA. Retrovirology, 2013. 10: p. 18. https://doi.org/10.1186/1742-4690-10-18 PMID:
23402264
38. Acinas S, Sarma-Rupavtarm R, Klepac-Ceraj V, Poltz M, PCR-induced sequence artifacts and bias:
insights from comparison of two 16S rRNA clone libraries constructed from the same sample. Appl Envi-
ron Microbiol, 2005. 71(12): p. 8966–9. https://doi.org/10.1128/AEM.71.12.8966-8969.2005 PMID:
16332901
39. Gorzer I, Guelly C, Trajanoski S, Puchhammer-Sto¨ckl E, The impact of PCR-generated recombination
on diversity estimation of mixed viral populations by deep sequencing. J Virol Methods, 2010. 169(1):
p. 248–52. https://doi.org/10.1016/j.jviromet.2010.07.040 PMID: 20691210
40. Judo M, Wedel A, and Wilson C, Stimulation and suppression of PCR-mediated recombination. Nucleic
Acids Res, 1998. 26(7): p. 1819–25. https://doi.org/10.1093/nar/26.7.1819 PMID: 9512558
41. Meyerhans A, Vartanian J, and Wain-Hobson S, DNA recombination during PCR. Nucleic Acids Res,
1990. 18(7): p. 1687–91. https://doi.org/10.1093/nar/18.7.1687 PMID: 2186361
42. Quail M, Smith M, Coupland P, Otto T, Harris S, Connor T, et al., A tale of three next generation
sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.
BMC Genomics, 2012. 13: p. 341. https://doi.org/10.1186/1471-2164-13-341 PMID: 22827831
Comparison of sequencing methods and data processing pipelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0229326 February 20, 2020 27 / 28
43. Sims D, Sudbery I, Ilott N, Heger A, Ponting C, Sequencing depth and coverage: key considerations in
genomic analyses. Nat Rev Genet, 2014. 15(2): p. 121–32. https://doi.org/10.1038/nrg3642 PMID:
24434847
44. Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al., Comparison of next-generation sequencing systems. J
Biomed Biotechnol, 2012. 2012: p. 251364. https://doi.org/10.1155/2012/251364 PMID: 22829749
45. Keller M, Rambo-Martin B, Wilson M, Ridenour C, Shepard S, Start T, et al., Direct RNA Sequencing of
the Coding Complete Influenza A Virus Genome. Sci Rep, 2018. 8(1): p. 14408. https://doi.org/10.
1038/s41598-018-32615-8 PMID: 30258076
Comparison of sequencing methods and data processing pipelines
PLOS ONE | https://doi.org/10.1371/journal.pone.0229326 February 20, 2020 28 / 28
